Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Petter Bjornstad

Concepts (394)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Diabetic Nephropathies
76
2025
284
24.600
 Why?
Diabetes Mellitus, Type 2
67
2025
2441
10.830
 Why?
Diabetes Mellitus, Type 1
78
2025
3628
10.200
 Why?
Glomerular Filtration Rate
62
2025
711
8.520
 Why?
Kidney
50
2025
1385
6.260
 Why?
Uric Acid
23
2022
161
4.730
 Why?
Albuminuria
23
2024
183
4.270
 Why?
Insulin Resistance
20
2024
1165
4.250
 Why?
Renal Insufficiency, Chronic
19
2025
566
3.280
 Why?
Hemodynamics
23
2025
1090
2.900
 Why?
Pediatric Obesity
8
2023
572
2.870
 Why?
Metformin
12
2025
315
2.830
 Why?
Renal Insufficiency
6
2023
149
2.780
 Why?
Coronary Artery Disease
11
2022
679
2.580
 Why?
Biomarkers
36
2025
3973
2.470
 Why?
Diabetic Angiopathies
9
2019
261
2.460
 Why?
Glycopeptides
10
2021
44
2.290
 Why?
Bariatric Surgery
5
2020
193
2.260
 Why?
Obesity, Morbid
5
2020
240
2.190
 Why?
Vascular Calcification
6
2022
107
2.160
 Why?
Hypoglycemic Agents
20
2025
1220
2.120
 Why?
Adolescent
64
2025
20393
2.070
 Why?
Renin-Angiotensin System
10
2021
82
1.970
 Why?
Sodium-Glucose Transporter 2
12
2024
22
1.930
 Why?
Humans
167
2025
129650
1.780
 Why?
Sex Characteristics
6
2025
737
1.660
 Why?
Cardiovascular Diseases
15
2024
2004
1.660
 Why?
Creatinine
18
2025
491
1.640
 Why?
Young Adult
45
2025
12426
1.610
 Why?
Male
99
2025
63681
1.490
 Why?
Disease Progression
19
2024
2635
1.440
 Why?
Diabetic Ketoacidosis
3
2024
197
1.440
 Why?
Female
94
2025
68776
1.380
 Why?
Glucosides
9
2025
38
1.360
 Why?
Benzhydryl Compounds
9
2025
66
1.330
 Why?
Calcinosis
4
2015
230
1.320
 Why?
Obesity
12
2025
2883
1.280
 Why?
Adult
59
2025
35576
1.250
 Why?
Kidney Diseases
3
2023
384
1.200
 Why?
Diabetic Cardiomyopathies
4
2020
34
1.190
 Why?
Risk Factors
36
2024
9765
1.140
 Why?
Child
33
2025
20883
1.070
 Why?
Adiposity
5
2024
504
1.040
 Why?
Hypertension
9
2021
1242
1.000
 Why?
Arterioles
3
2024
50
1.000
 Why?
Follow-Up Studies
17
2025
4897
0.980
 Why?
Exercise Tolerance
3
2017
273
0.970
 Why?
Fructose
4
2021
106
0.970
 Why?
Atherosclerosis
4
2018
402
0.960
 Why?
Apolipoproteins B
2
2015
43
0.950
 Why?
Vascular Stiffness
7
2022
467
0.950
 Why?
Cross-Sectional Studies
19
2025
5066
0.940
 Why?
Body Composition
3
2025
649
0.930
 Why?
Uromodulin
3
2019
21
0.930
 Why?
Proteinuria
2
2024
91
0.930
 Why?
Hyperglycemia
5
2024
328
0.920
 Why?
Hyperuricemia
6
2021
44
0.910
 Why?
Middle Aged
50
2025
31154
0.910
 Why?
Vasopressins
3
2023
64
0.910
 Why?
Case-Control Studies
14
2025
3381
0.900
 Why?
Immunoglobulin Fc Fragments
1
2024
39
0.900
 Why?
Adiponectin
2
2016
235
0.890
 Why?
Glucagon-Like Peptides
1
2024
50
0.860
 Why?
Acute Kidney Injury
5
2024
790
0.860
 Why?
Hyperoxia
1
2024
90
0.830
 Why?
Prognosis
11
2025
3794
0.820
 Why?
Diabetic Retinopathy
4
2021
176
0.820
 Why?
Iothalamic Acid
1
2022
5
0.820
 Why?
Kidney Tubules
2
2021
114
0.810
 Why?
Dyslipidemias
5
2021
177
0.810
 Why?
Blood Glucose
11
2025
2097
0.810
 Why?
Cystatin C
8
2023
65
0.780
 Why?
Epithelial-Mesenchymal Transition
1
2024
202
0.780
 Why?
Kidney Glomerulus
5
2023
109
0.750
 Why?
Glucagon-Like Peptide-1 Receptor
6
2024
92
0.750
 Why?
Recombinant Fusion Proteins
1
2024
643
0.750
 Why?
Bone Density
1
2025
471
0.720
 Why?
Polycystic Kidney, Autosomal Dominant
1
2024
254
0.680
 Why?
Oxygen Consumption
3
2017
672
0.660
 Why?
Dried Blood Spot Testing
2
2018
94
0.660
 Why?
Kidney Failure, Chronic
4
2023
547
0.660
 Why?
Iohexol
2
2020
19
0.660
 Why?
Triglycerides
3
2022
527
0.650
 Why?
Blood Pressure
9
2022
1736
0.640
 Why?
Oxygen
2
2024
915
0.640
 Why?
Vascular Resistance
6
2020
371
0.630
 Why?
Longevity
6
2022
151
0.630
 Why?
Pilot Projects
7
2024
1587
0.630
 Why?
Cyclic GMP
1
2019
90
0.630
 Why?
Lipid Metabolism Disorders
1
2018
2
0.620
 Why?
Coronary Vessels
3
2017
241
0.620
 Why?
Cohort Studies
18
2025
5420
0.610
 Why?
Leptin
2
2017
219
0.600
 Why?
Gastric Bypass
1
2020
107
0.590
 Why?
Weight Reduction Programs
1
2019
111
0.590
 Why?
Overweight
3
2025
531
0.590
 Why?
Cardiotonic Agents
1
2018
126
0.580
 Why?
Hemofiltration
1
2018
30
0.580
 Why?
Sodium Bicarbonate
1
2018
37
0.580
 Why?
Cholesterol, HDL
2
2015
205
0.570
 Why?
Incidence
9
2021
2644
0.560
 Why?
Glucose
5
2023
1003
0.560
 Why?
Ventricular Function, Left
3
2020
527
0.560
 Why?
Blood Vessels
1
2018
187
0.550
 Why?
Aorta
2
2019
411
0.540
 Why?
Up-Regulation
2
2016
840
0.510
 Why?
Nutrition Surveys
1
2017
260
0.510
 Why?
Cholesterol, LDL
2
2014
358
0.500
 Why?
Kidney Function Tests
4
2022
152
0.480
 Why?
Renal Circulation
3
2021
57
0.480
 Why?
Canada
7
2022
350
0.460
 Why?
Angiotensin II Type 2 Receptor Blockers
1
2014
7
0.460
 Why?
Pregnancy Outcome
1
2017
390
0.460
 Why?
Aged
28
2025
22103
0.460
 Why?
Body Mass Index
9
2025
2273
0.460
 Why?
Fasting
2
2025
267
0.450
 Why?
Echocardiography
2
2018
629
0.440
 Why?
Hypoxia
2
2020
1084
0.440
 Why?
Dietary Supplements
1
2018
534
0.430
 Why?
Goals
1
2015
160
0.420
 Why?
Patient Care Planning
1
2014
149
0.420
 Why?
Drug Therapy, Combination
5
2025
1040
0.420
 Why?
Vasoconstriction
3
2020
199
0.410
 Why?
Brain
1
2025
2679
0.410
 Why?
Heart Failure
3
2021
2150
0.400
 Why?
Lipids
2
2022
625
0.400
 Why?
Chitinase-3-Like Protein 1
2
2022
19
0.400
 Why?
Contrast Media
1
2015
394
0.390
 Why?
Sodium
4
2023
206
0.390
 Why?
Histidine
2
2022
60
0.390
 Why?
Age of Onset
2
2025
496
0.380
 Why?
Glucose Clamp Technique
5
2020
194
0.370
 Why?
Albumins
3
2022
103
0.360
 Why?
Clinical Trials as Topic
6
2022
1004
0.360
 Why?
Angiotensin II
3
2020
95
0.360
 Why?
Insulin
6
2024
2326
0.350
 Why?
Guideline Adherence
1
2015
526
0.350
 Why?
Absorptiometry, Photon
2
2025
248
0.340
 Why?
Lipocalin-2
2
2022
75
0.340
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
430
0.330
 Why?
Prospective Studies
9
2025
7133
0.330
 Why?
Testosterone
3
2025
372
0.320
 Why?
Running
2
2023
223
0.310
 Why?
Pulse Wave Analysis
5
2022
248
0.300
 Why?
Diabetes Complications
2
2021
224
0.290
 Why?
Animals
15
2024
35361
0.280
 Why?
Metabolic Syndrome
3
2021
339
0.280
 Why?
Epidermal Growth Factor
2
2024
171
0.270
 Why?
Canagliflozin
3
2023
9
0.270
 Why?
Treatment Outcome
10
2019
10230
0.260
 Why?
Heat Stress Disorders
2
2018
69
0.260
 Why?
Dipeptidyl-Peptidase IV Inhibitors
3
2025
45
0.260
 Why?
Diabetes Mellitus
3
2021
1001
0.250
 Why?
Age Factors
7
2019
3144
0.250
 Why?
Severity of Illness Index
3
2021
2742
0.250
 Why?
Time Factors
6
2018
6556
0.250
 Why?
Colorado
4
2017
4421
0.250
 Why?
Gliclazide
1
2025
2
0.240
 Why?
Linagliptin
1
2025
5
0.240
 Why?
Hydrogen-Ion Concentration
2
2018
544
0.240
 Why?
Leucine
2
2024
108
0.240
 Why?
Fatty Acid Binding Protein 3
1
2024
5
0.240
 Why?
Predictive Value of Tests
4
2018
1952
0.240
 Why?
Vascular Cell Adhesion Molecule-1
1
2024
37
0.230
 Why?
Early Diagnosis
2
2017
234
0.230
 Why?
Citric Acid Cycle
1
2024
55
0.230
 Why?
Estradiol
2
2025
494
0.230
 Why?
Gray Matter
1
2025
81
0.230
 Why?
Renin
2
2022
32
0.230
 Why?
Androgen Antagonists
1
2025
79
0.230
 Why?
Lipoproteins
2
2022
171
0.230
 Why?
Sex Factors
4
2025
1968
0.220
 Why?
Diuretics
2
2023
76
0.220
 Why?
Endothelin Receptor Antagonists
2
2024
62
0.220
 Why?
Mineralocorticoid Receptor Antagonists
2
2024
46
0.220
 Why?
National Institutes of Health (U.S.)
1
2024
123
0.210
 Why?
Receptors, Vasopressin
2
2021
19
0.210
 Why?
Magnetic Resonance Imaging
3
2025
3408
0.210
 Why?
Inappropriate ADH Syndrome
1
2023
8
0.210
 Why?
Cysts
1
2024
109
0.210
 Why?
Hyponatremia
1
2023
40
0.200
 Why?
Fluorocarbons
1
2024
109
0.200
 Why?
Longitudinal Studies
5
2024
2717
0.200
 Why?
Consensus
2
2022
616
0.200
 Why?
Malates
1
2022
8
0.200
 Why?
Fumarates
1
2022
9
0.200
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2023
119
0.200
 Why?
Threonine
1
2022
44
0.190
 Why?
Carboxylic Acids
1
2022
32
0.190
 Why?
Natriuresis
2
2019
10
0.190
 Why?
Diabetes Mellitus, Experimental
1
2023
182
0.190
 Why?
Amino Acids
2
2024
485
0.190
 Why?
Phenylalanine
1
2022
65
0.190
 Why?
Pathology, Clinical
1
2022
36
0.190
 Why?
Rats
2
2024
5500
0.190
 Why?
Chemokine CCL2
1
2022
118
0.190
 Why?
Arizona
1
2021
78
0.180
 Why?
Glycine
1
2022
165
0.180
 Why?
Glucagon-Like Peptide 1
1
2022
112
0.180
 Why?
Osmolar Concentration
2
2018
166
0.180
 Why?
Oxidation-Reduction
1
2024
1033
0.180
 Why?
p-Aminohippuric Acid
1
2020
6
0.180
 Why?
Tryptophan
1
2022
179
0.170
 Why?
Multivariate Analysis
2
2014
1502
0.170
 Why?
Interleukin-18
1
2022
237
0.170
 Why?
Japan
5
2017
98
0.170
 Why?
Nephrosis
1
2020
4
0.170
 Why?
Natriuretic Peptide, Brain
1
2021
99
0.170
 Why?
Furosemide
1
2020
39
0.170
 Why?
Asymptomatic Diseases
2
2019
84
0.170
 Why?
Transgender Persons
1
2023
172
0.170
 Why?
Angiotensin-Converting Enzyme Inhibitors
2
2024
198
0.170
 Why?
Diabetic Neuropathies
1
2021
96
0.170
 Why?
Calcium Channel Blockers
1
2021
161
0.170
 Why?
Sodium-Glucose Transporter 1
1
2019
10
0.160
 Why?
Body Water
1
2019
20
0.160
 Why?
Double-Blind Method
2
2025
1876
0.160
 Why?
Diabetic Foot
1
2019
25
0.160
 Why?
Models, Biological
3
2016
1722
0.160
 Why?
Glycolysis
1
2021
311
0.160
 Why?
Glomerulonephritis
1
2019
46
0.160
 Why?
Glycosides
1
2019
37
0.160
 Why?
Blood Chemical Analysis
1
2019
96
0.160
 Why?
Postmenopause
1
2021
351
0.160
 Why?
beta 2-Microglobulin
1
2018
49
0.150
 Why?
Myocardial Contraction
1
2020
335
0.150
 Why?
Endothelial Cells
1
2024
749
0.150
 Why?
Body Temperature Regulation
1
2019
96
0.150
 Why?
Microscopy, Polarization
1
2018
31
0.150
 Why?
Carotid Intima-Media Thickness
1
2018
90
0.150
 Why?
Energy Metabolism
1
2024
874
0.150
 Why?
Hepatitis A Virus Cellular Receptor 1
1
2018
42
0.150
 Why?
Allopurinol
1
2018
62
0.150
 Why?
Biopsy
1
2022
1097
0.150
 Why?
Weight Loss
2
2020
734
0.150
 Why?
Pharmaceutical Preparations
1
2020
171
0.150
 Why?
Obesity, Metabolically Benign
1
2017
4
0.140
 Why?
Prehypertension
1
2017
27
0.140
 Why?
Glucose Tolerance Test
2
2019
356
0.140
 Why?
Glomerulosclerosis, Focal Segmental
1
2017
43
0.140
 Why?
Life Style
1
2019
460
0.140
 Why?
Hyperthermia, Induced
1
2018
109
0.140
 Why?
Deamino Arginine Vasopressin
1
2016
11
0.140
 Why?
Urinary Calculi
1
2017
11
0.140
 Why?
Gastrointestinal Microbiome
1
2024
641
0.130
 Why?
Precision Medicine
1
2020
387
0.130
 Why?
Peptide Fragments
1
2021
692
0.130
 Why?
Tomography, X-Ray Computed
2
2018
2535
0.130
 Why?
Ventricular Dysfunction, Left
1
2020
385
0.130
 Why?
Magnetic Resonance Angiography
1
2018
236
0.130
 Why?
Blood Banks
1
2016
40
0.130
 Why?
Morbidity
1
2017
302
0.130
 Why?
Dehydration
1
2016
49
0.130
 Why?
Disease Models, Animal
5
2021
4063
0.130
 Why?
Cardiorespiratory Fitness
1
2017
49
0.130
 Why?
Regional Blood Flow
1
2018
463
0.130
 Why?
Vasodilation
1
2020
476
0.130
 Why?
Child, Preschool
3
2024
10517
0.130
 Why?
Anti-Inflammatory Agents
1
2020
480
0.130
 Why?
Mice
4
2023
16937
0.130
 Why?
Cognition
1
2024
1123
0.130
 Why?
Survival Rate
2
2017
1877
0.130
 Why?
Logistic Models
3
2017
1988
0.130
 Why?
Vitreoretinopathy, Proliferative
1
2016
12
0.130
 Why?
Linear Models
2
2017
819
0.130
 Why?
Hot Temperature
1
2018
370
0.120
 Why?
Heart Rate
1
2019
802
0.120
 Why?
Echocardiography, Doppler
1
2016
108
0.120
 Why?
Liver Diseases
1
2018
290
0.120
 Why?
Risk Assessment
4
2019
3240
0.120
 Why?
Filtration
1
2015
67
0.120
 Why?
Software
1
2019
608
0.120
 Why?
Apolipoproteins
1
2014
38
0.120
 Why?
Enzyme Inhibitors
1
2018
827
0.110
 Why?
Blood Pressure Determination
1
2015
148
0.110
 Why?
Phenotype
1
2022
3076
0.110
 Why?
Purines
1
2015
172
0.110
 Why?
Achievement
1
2014
57
0.110
 Why?
Stress, Mechanical
1
2016
467
0.110
 Why?
Immunity, Innate
1
2019
804
0.110
 Why?
Liver
2
2021
1839
0.110
 Why?
Randomized Controlled Trials as Topic
1
2019
1368
0.100
 Why?
Primary Prevention
1
2015
188
0.100
 Why?
Research Design
1
2019
1044
0.100
 Why?
Exercise Test
1
2016
613
0.100
 Why?
Biomechanical Phenomena
1
2016
764
0.100
 Why?
United States
3
2024
13903
0.100
 Why?
Adenosine Triphosphate
1
2015
480
0.100
 Why?
Cholesterol
1
2014
412
0.100
 Why?
Aged, 80 and over
3
2018
7086
0.100
 Why?
Antihypertensive Agents
1
2016
485
0.100
 Why?
RNA, Messenger
1
2019
2708
0.100
 Why?
Proof of Concept Study
2
2024
69
0.090
 Why?
Regression Analysis
1
2014
993
0.090
 Why?
Feasibility Studies
1
2015
868
0.090
 Why?
Ambulatory Care
1
2015
504
0.090
 Why?
Exercise
1
2022
1925
0.090
 Why?
Vascular Diseases
1
2013
241
0.090
 Why?
Societies, Medical
1
2015
751
0.090
 Why?
Hematocrit
2
2021
93
0.090
 Why?
Gene Expression Regulation
1
2019
2548
0.080
 Why?
Practice Guidelines as Topic
1
2017
1501
0.080
 Why?
Retrospective Studies
7
2024
14518
0.080
 Why?
Fructokinases
2
2021
31
0.080
 Why?
Registries
1
2016
1896
0.080
 Why?
Inflammation
2
2021
2736
0.070
 Why?
Prevalence
3
2019
2564
0.070
 Why?
Reproducibility of Results
1
2015
3083
0.070
 Why?
Fibrosis
2
2021
520
0.070
 Why?
Pregnancy
1
2017
6402
0.060
 Why?
Postprandial Period
1
2025
104
0.060
 Why?
Isoleucine
1
2024
14
0.060
 Why?
Mice, Inbred C57BL
3
2021
5440
0.050
 Why?
Valine
1
2024
81
0.050
 Why?
Obesity, Abdominal
1
2024
47
0.050
 Why?
Aging
1
2014
1776
0.050
 Why?
Multicenter Studies as Topic
1
2024
286
0.050
 Why?
RNA, Transfer
1
2024
130
0.050
 Why?
Bromocriptine
1
2022
29
0.050
 Why?
Infant, Newborn
1
2014
5762
0.050
 Why?
Environmental Pollutants
1
2024
143
0.050
 Why?
Benzbromarone
1
2022
3
0.050
 Why?
Aldosterone
1
2022
43
0.050
 Why?
Cytokines
2
2021
2017
0.050
 Why?
Glycoproteins
1
2024
338
0.050
 Why?
Controlled Clinical Trials as Topic
1
2021
27
0.050
 Why?
Adenine
1
2023
256
0.050
 Why?
Clinical Trials, Phase III as Topic
1
2021
93
0.050
 Why?
Inulin
1
2021
7
0.050
 Why?
Hep G2 Cells
1
2021
61
0.040
 Why?
Drinking
1
2021
39
0.040
 Why?
Serum Albumin
1
2021
149
0.040
 Why?
Uricosuric Agents
1
2020
2
0.040
 Why?
TOR Serine-Threonine Kinases
1
2023
396
0.040
 Why?
Diuretics, Osmotic
1
2020
2
0.040
 Why?
Infant
1
2014
9024
0.040
 Why?
Cross-Over Studies
1
2022
521
0.040
 Why?
Environmental Exposure
1
2024
462
0.040
 Why?
Mendelian Randomization Analysis
1
2020
47
0.040
 Why?
Cell Hypoxia
1
2021
235
0.040
 Why?
Diastole
1
2020
148
0.040
 Why?
Chemokines
1
2021
226
0.040
 Why?
Systole
1
2020
191
0.040
 Why?
Netherlands
1
2019
77
0.040
 Why?
Cytoprotection
1
2019
56
0.040
 Why?
Neuropsychological Tests
1
2024
1015
0.040
 Why?
Drug Interactions
1
2021
394
0.040
 Why?
Preoperative Period
1
2019
115
0.040
 Why?
Cognitive Dysfunction
1
2024
346
0.040
 Why?
Magnetic Resonance Imaging, Cine
1
2020
185
0.040
 Why?
Incretins
1
2018
18
0.040
 Why?
Macular Edema
1
2018
42
0.040
 Why?
Photography
1
2018
94
0.040
 Why?
Renal Elimination
1
2018
6
0.040
 Why?
Inflammation Mediators
1
2021
505
0.040
 Why?
Xanthine Oxidase
1
2018
78
0.040
 Why?
HSP70 Heat-Shock Proteins
1
2018
69
0.040
 Why?
Diet Therapy
1
2018
34
0.040
 Why?
Renal Dialysis
1
2021
423
0.040
 Why?
Anti-Obesity Agents
1
2018
53
0.030
 Why?
Cardiovascular System
1
2019
137
0.030
 Why?
Lipoproteins, LDL
1
2017
127
0.030
 Why?
Renal Plasma Flow, Effective
1
2016
1
0.030
 Why?
Tomography, Optical Coherence
1
2018
187
0.030
 Why?
Blood Urea Nitrogen
1
2016
53
0.030
 Why?
Blood Pressure Monitoring, Ambulatory
1
2017
83
0.030
 Why?
Thiazolidinediones
1
2018
137
0.030
 Why?
Aldehyde Reductase
1
2016
28
0.030
 Why?
Water-Electrolyte Balance
1
2016
34
0.030
 Why?
Interleukin-6
1
2021
720
0.030
 Why?
Infusions, Intravenous
1
2018
400
0.030
 Why?
Ammonia
1
2016
62
0.030
 Why?
Proportional Hazards Models
1
2019
1201
0.030
 Why?
Age Distribution
1
2017
372
0.030
 Why?
Sex Distribution
1
2017
359
0.030
 Why?
Collagen
1
2018
434
0.030
 Why?
Waist Circumference
1
2015
138
0.030
 Why?
Combined Modality Therapy
1
2018
1206
0.030
 Why?
Circadian Rhythm
1
2017
413
0.030
 Why?
Blood Glucose Self-Monitoring
1
2019
601
0.030
 Why?
Mice, Knockout
1
2021
2871
0.030
 Why?
Complement Activation
1
2016
376
0.030
 Why?
Exercise Therapy
1
2018
412
0.030
 Why?
Heart Ventricles
1
2018
781
0.020
 Why?
Peptides
1
2018
925
0.020
 Why?
Gene-Environment Interaction
1
2014
185
0.020
 Why?
Comorbidity
1
2017
1547
0.020
 Why?
Rats, Sprague-Dawley
1
2017
2406
0.020
 Why?
Models, Statistical
1
2015
623
0.020
 Why?
Databases, Factual
1
2017
1269
0.020
 Why?
Non-alcoholic Fatty Liver Disease
1
2014
261
0.020
 Why?
Algorithms
1
2015
1622
0.020
 Why?
Hospitalization
1
2017
2070
0.020
 Why?
Neoplasms
1
2014
2470
0.010
 Why?
Bjornstad's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (394) concept(s)
_
Co-Authors Expand Description
See all (66) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)